Skip to main content
Erschienen in: Neurological Sciences 1/2012

01.05.2012 | Oral Communications

Alcohol as a dietary trigger of primary headaches: what triggering site could be compatible?

verfasst von: A. Panconesi, M. L. Bartolozzi, S. Mugnai, L. Guidi

Erschienen in: Neurological Sciences | Sonderheft 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Alcoholic drinks (AD) have been known as migraine triggers in about one-third of migraine patients in retrospective studies. We have reviewed the studies concerning the role of AD in triggering the various types of primary headaches published after the International Headache Society classification of 1988. There are many studies showing that AD are triggers of migraine without aura (MO), migraine with aura (MA), cluster headache (CH) and tension-type headache (TH). About one-third of MO and half of CH patients reported AD as trigger factors. Some studies show that AD are triggers in MA and TH in a similar percentage to that found in MO, but there are also discordant findings. There are sparse reports that AD are also triggers of less frequent types of primary headache such as familial hemiplegic migraine, hemicrania continua and paroxysmal hemicrania. The mechanism of alcohol-provoking headache is debated and should be compatible with the principal pathogenetic theories of primary headaches. If AD are capable of triggering practically all primary headaches, they should act at a common pathogenetic level. Vasodilatation is unlikely to be compatible as common mechanism. An action at cortical or more likely at subcortical level is plausible.
Literatur
1.
Zurück zum Zitat Panconesi A (2008) Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain 9:19–27PubMedCrossRef Panconesi A (2008) Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain 9:19–27PubMedCrossRef
2.
Zurück zum Zitat Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(suppl 1):1–160 Headache Classification Committee of the International Headache Society (2004) The International Classification of Headache Disorders. Cephalalgia 24(suppl 1):1–160
3.
Zurück zum Zitat Wober C, Wober-Bingol C (2010) Triggers of migraine and tension-type headache. Handb Clin Neurol 97:161–172PubMedCrossRef Wober C, Wober-Bingol C (2010) Triggers of migraine and tension-type headache. Handb Clin Neurol 97:161–172PubMedCrossRef
4.
Zurück zum Zitat Wober C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, Wober-Bingol C, PAMINA Study Group (2007) Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 27:304–314PubMedCrossRef Wober C, Brannath W, Schmidt K, Kapitan M, Rudel E, Wessely P, Wober-Bingol C, PAMINA Study Group (2007) Prospective analysis of factors related to migraine attacks: the PAMINA study. Cephalalgia 27:304–314PubMedCrossRef
5.
Zurück zum Zitat Leone M, Vila C, McGown C (2010) Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Expert Rev Neurother 10:1399–1408PubMedCrossRef Leone M, Vila C, McGown C (2010) Influence of trigger factors on the efficacy of almotriptan as early intervention for the treatment of acute migraine in a primary care setting: the START study. Expert Rev Neurother 10:1399–1408PubMedCrossRef
6.
Zurück zum Zitat Hauge AW, Kirchmann M, Olesen J (2010) Trigger factors in migraine with aura. Cephalalgia 30:346–353PubMedCrossRef Hauge AW, Kirchmann M, Olesen J (2010) Trigger factors in migraine with aura. Cephalalgia 30:346–353PubMedCrossRef
7.
Zurück zum Zitat Hansen JM, Hauge AW, Ashina M, Olesen J (2011) Trigger factors for familial hemiplegic migraine. Cephalalgia 31:1274–1281PubMedCrossRef Hansen JM, Hauge AW, Ashina M, Olesen J (2011) Trigger factors for familial hemiplegic migraine. Cephalalgia 31:1274–1281PubMedCrossRef
8.
Zurück zum Zitat Burnstein R, Jakubowski M (2005) Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 493:9–14CrossRef Burnstein R, Jakubowski M (2005) Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 493:9–14CrossRef
9.
Zurück zum Zitat Nicoletti P, Trevisani M, Manconi M, Gatti R, De Siena G, Zagli G, Benemei S, Capone JA, Geppetti P, Pini LA (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9–17PubMedCrossRef Nicoletti P, Trevisani M, Manconi M, Gatti R, De Siena G, Zagli G, Benemei S, Capone JA, Geppetti P, Pini LA (2008) Ethanol causes neurogenic vasodilation by TRPV1 activation and CGRP release in the trigeminovascular system of the guinea pig. Cephalalgia 28:9–17PubMedCrossRef
10.
Zurück zum Zitat Lambert GA, Hoskin KL, Zagami AS (2008) Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 28:640–652PubMedCrossRef Lambert GA, Hoskin KL, Zagami AS (2008) Cortico-NRM influences on trigeminal neuronal sensation. Cephalalgia 28:640–652PubMedCrossRef
11.
Zurück zum Zitat Sicuteri F (1987) Quasi-phantom head pain from functional deafferentation. Clin J Pain 3:63–80CrossRef Sicuteri F (1987) Quasi-phantom head pain from functional deafferentation. Clin J Pain 3:63–80CrossRef
12.
Zurück zum Zitat Panconesi A, Bartolozzi ML, Guidi L (2011) Alcohol and migraine: what should we tell patients? Curr Pain Headache Rep 15:177–184PubMedCrossRef Panconesi A, Bartolozzi ML, Guidi L (2011) Alcohol and migraine: what should we tell patients? Curr Pain Headache Rep 15:177–184PubMedCrossRef
13.
Zurück zum Zitat Sonn J, Mayevsky A (2001) The effect of ethanol on metabolic, hemodynamic and electrical responses to cortical spreading depression. Brain Res 908:174–186PubMedCrossRef Sonn J, Mayevsky A (2001) The effect of ethanol on metabolic, hemodynamic and electrical responses to cortical spreading depression. Brain Res 908:174–186PubMedCrossRef
14.
Zurück zum Zitat Panconesi A (2008) Serotonin and migraine: a reconsideration of the central theory. J Headache Pain 9:267–276PubMedCrossRef Panconesi A (2008) Serotonin and migraine: a reconsideration of the central theory. J Headache Pain 9:267–276PubMedCrossRef
Metadaten
Titel
Alcohol as a dietary trigger of primary headaches: what triggering site could be compatible?
verfasst von
A. Panconesi
M. L. Bartolozzi
S. Mugnai
L. Guidi
Publikationsdatum
01.05.2012
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe Sonderheft 1/2012
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1068-z

Weitere Artikel der Sonderheft 1/2012

Neurological Sciences 1/2012 Zur Ausgabe

A REDEFINITION OF PRIMARY HEADACHES

A redefinition of primary headache: chronic migraine

MIGRAINE AS A RISK FACTOR

Migraine and movement disorders

CONTROVERSIES IN PROPHYLAXIS

Controversies in migraine: monotherapy

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.